T-DM1 Breast Cancer Drug

Аватар автора
Свет и тень
Clinical studies show that new drugs that target malignant cells of HER2-positive breast cancer, such as Trastuzumab Emtansine (T-DM1), increase life expectancy in patients with advanced breast cancer. Dr. David Margileth talks about this drug and what you need to know about it in the video above. SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS SUBMIT A QUESTION DOWNLOAD DR. HARNESS&15 QUESTIONS TO ASK YOUR DOCTOR CONNECT WITH US!

0/0


0/0

0/0

0/0